Biotechnology

Filter

Current filters:

None

Popular Filters

1 to 25 of 2473 results

First UK NICE highly specialized technologies guidance recommends Soliris

First UK NICE highly specialized technologies guidance recommends Soliris

28-01-2015

England’s health costs watchdog the National Institute for Health and care Excellence has today issued…

Alexion PharmaceuticalsBiotechnologyHematologyPricingRare diseasesRegulationSolarisUK

3SBio acquires Italy’s Sirton Pharmaceuticals

27-01-2015

Chinese biotech firm 3SBio today revealed that last month it acquired the entire share capital of Italy-based…

3SBioBiotechnologyEuropeMergers & AcquisitionsSirton Pharmaceuticals

Innovation and confidence at JP Morgan conference, says Edison analyst

26-01-2015

The atmosphere at this year's annual JPMorgan Conference in San Francisco was understandably buoyant,…

BiotechnologyFinancialMergers & AcquisitionsResearch

Kite Pharma expands CAR-T deal with Sourasky Medical Center

26-01-2015

US clinical-stage biopharma company Kite Pharma, focused on developing engineered autologous T cell therapy…

BiotechnologyKite PharmaOncologyResearch

Gilead expands hepatitis C agreements to include sofosbuvir/GS-5816 single tablet regimen

Gilead expands hepatitis C agreements to include sofosbuvir/GS-5816 single tablet regimen

26-01-2015

US biotech major Gilead Sciences has expanded its hepatitis C generic licensing agreements to include…

Anti-viralsBiotechnologyGenericsGilead SciencesIndiaLicensingSovaldiUSA

US FDA approves NPS Pharma’s Natpara

US FDA approves NPS Pharma’s Natpara

24-01-2015

The US Food and Drug Administration on Friday approved NPS Pharmaceuticals’ Natpara (parathyroid hormone)…

BiotechnologyNatparaNPS PharmaceuticalsRare diseasesRegulationShireUSA

Not for the faint of CAR-T: The CAR-T therapy landscape in 2015

22-01-2015

A new report shows investor enthusiasm for cancer-fighting CAR-T therapies is likely to continue despite…

BiotechnologyJuno TherapeuticsKite PharmaOncologyResearch

Sanofi granted European marketing authorization for Cerdelga in Gaucher disease

Sanofi granted European marketing authorization for Cerdelga in Gaucher disease

22-01-2015

French drug major Sanofi and its subsidiary Genzyme have been granted marketing authorization by the…

BiotechnologyCerdelgaGeneticsGenzymeRegulationSanofi

BIO responds to President Obama's State of the Union speech

22-01-2015

In his State of the Union speech to the American public this week, US President Barak Obama said that…

BiotechnologyPoliticsResearchUSA

Syncona and UCL Business form cancer immunotherapy company Autolus

Syncona and UCL Business form cancer immunotherapy company Autolus

22-01-2015

Investment company Syncona and UCL Business, the wholly-owned technology transfer company of University…

BiologyBiotechnologyOncologyResearchUK

Latest approval for Novartis’ Cosentyx, from US FDA

Latest approval for Novartis’ Cosentyx, from US FDA

22-01-2015

Adding to recent marketing clearances in Japan and the European Union, the US Food and Drug Administration…

BiotechnologyCosentyxDermatologicalsNovartisRegulationUSA

EastGate Biotech Corp appoints Rose Perri as president

EastGate Biotech Corp appoints Rose Perri as president

21-01-2015

Drug delivery and dosage specialist EastGate Biotech Corp has appointed Rose Perri as president.

BiotechnologyBoardroomEastGate Biotech CorpPresidentRose Perri

Naming conventions for biosimilars in Australia

Naming conventions for biosimilars in Australia

21-01-2015

Following recent international developments in the area of biosimilar naming, Australian regulator the…

AustraliaBiosimilarsBiotechnologyRegulationTherapeutic Goods Administration

Holger Zimmermann replaces founding chief executive of AiCuris

Holger Zimmermann replaces founding chief executive of AiCuris

21-01-2015

AiCuris, a company formed by experts from Bayer's virology and bacteriology research divisions, is to…

AiCurisAntibiotics and Infectious diseasesBiotechnologyBoardroomGermany

FDA removes hold on CytRx's aldoxorubicin Phase III trials

FDA removes hold on CytRx's aldoxorubicin Phase III trials

20-01-2015

The US Food and Drug Administration has removed the partial clinical hold on biopharma oncology company…

aldoxorubicinBiotechnologyCytRxOncologyRegulationResearchUSA

Solasia Pharma and Meiji Seika Pharma collaborate on darinaparsin

19-01-2015

Privately-held Solasia Pharma and fellow Japanese drugmaker Meiji Seika Pharma have entered into a license…

BiotechnologydarinaparsinJapanLicensingMeiji Seika PharmaOncologyResearchSolasia PharmaZiopharm Oncology

Novartis’ Cosentyx gets third approval, now in Europe

19-01-2015

The European Commission (EC) has approved Swiss pharma giant Novartis’ Cosentyx (secukinumab, formerly…

BiotechnologyCosentyxDermatologicalsEuropeNovartisRegulation

Gilead to appeal Indian Patent Office rejection of Sovaldi patent application

Gilead to appeal Indian Patent Office rejection of Sovaldi patent application

19-01-2015

US biotech major Gilead Sciences is to appeal a recent decision by India’s Patent Office to reject…

BiotechnologyGileadIndiaNephrology and HepatologyPatents & Trade marksSovaldi

C4X Discovery enters into new research agreement with Evotec AG for treating addiction

C4X Discovery enters into new research agreement with Evotec AG for treating addiction

19-01-2015

UK-based C4X Discovery Holdings has entered into a research agreement with drug discovery alliance Evotec.

BiotechnologyC4X DiscoveryEvotec AGLicensingNeurologicalUK

Celgene’s oral Otezla approved by EC for psoriasis and psoriatic arthritis

Celgene’s oral Otezla approved by EC for psoriasis and psoriatic arthritis

18-01-2015

US biotech firm Celgene’s European subsidiary has received marketing authorization from the European…

Anti-Arthritics/RheumaticsBiotechnologyCelgene CorpDermatologicalsEuropeOtezlaRegulation

1 to 25 of 2473 results

COMPANY SPOTLIGHT

Parexel

Parexel

Back to top